Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01848327
Recruitment Status : Completed
First Posted : May 7, 2013
Last Update Posted : January 25, 2018
Sponsor:
Collaborators:
National Multiple Sclerosis Society
Cerecin
Information provided by (Responsible Party):
Leticia Tornes, University of Miami

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2017
  Actual Study Completion Date : December 2017